FABIO CATAO ALVES MARTINS DA SILVA, M.D.
Psychiatry Physician in WESTON, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
FABIO CATAO ALVES MARTINS DA SILVA, M.D. reported a CMS MIPS final score of 84.5549/100 — above the 83.1 national average — and filed 6,112 Medicare Part D claims in 2023.
- 84.5549/100
- MIPS score · +1 vs avg
- 6K
- Part D claims, 2023
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
85 45th percentile higher than 45% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
FABIO CATAO ALVES MARTINS DA SILVA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about FABIO CATAO ALVES MARTINS DA SILVA, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Wisconsin
How Psychiatry Physician compares to other specialties among Wisconsin providers
Psychiatry Physician share within Wisconsin
Psychiatry Physician is one of the more visible NUCC categories in Wisconsin
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s 2023 MIPS final score plotted against the Psychiatry Physician national average
- MIPS Final Score
- 84.5549/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Psychiatry Physician) — 84.5549/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Psychiatry Physician US NPIs
84.5549/100 MIPS final score — 1.5 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Psychiatry Physician. Quality dim: 91.8111. Cost dim: 53.8099.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
FABIO CATAO ALVES MARTINS DA SILVA, M.D. appears in the CMS NPPES registry as a Psychiatry Physician provider holding M.D. credentials at 4005 COMMUNITY CENTER DR, WESTON, WI, 54476, with a listed phone of (715) 241-5400. NPI 1669815106 was issued on 04/15/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CATAO ALVES MARTINS DA SILVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 6,112 prescription claims written by this provider, covering 290 Medicare beneficiaries and totaling roughly $629K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84.5549/100 for the 2023 performance year (Quality 91.8111, Cost 53.8099), compared with the national average of 83.1.
Psychiatry Physician is a high-volume specialty nationwide, with 53,104 enrolled providers across 56 states and an average of 1,038 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669815106 |
|---|---|
| Specialty | Psychiatry Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/15/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where FABIO CATAO ALVES MARTINS DA SILVA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
7% brand-name claims vs 93% generic, on 6,112 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,367
- Total Day Supply
- 274,995
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $370K
- Generic Drug Cost
- $259K
Patient Demographics
- Average Patient Age
- 58.0 years
- Avg HCC Risk Score
- 1.33
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 184, 65-74: 78, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What FABIO CATAO ALVES MARTINS DA SILVA, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trazodone Hcl
Trazodone Hcl
475 claims
- Lorazepam
Lorazepam
355 claims
- Lamotrigine
Lamotrigine
345 claims
- Sertraline Hcl
Sertraline Hcl
321 claims
- Clonazepam
Clonazepam
292 claims
- Quetiapine Fumarate
Quetiapine Fumarate
281 claims
- Bupropion Xl
Bupropion Xl
270 claims
- Alprazolam
Alprazolam
268 claims
| Drug | Claims |
|---|---|
| Trazodone Hcl | 475 |
| Lorazepam | 355 |
| Lamotrigine | 345 |
| Sertraline Hcl | 321 |
| Clonazepam | 292 |
| Quetiapine Fumarate | 281 |
| Bupropion Xl Bupropion Hcl | 270 |
| Alprazolam | 268 |
| Fluoxetine Hcl | 240 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 172 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Psychiatry Physician Overview
How FABIO CATAO ALVES MARTINS DA SILVA, M.D. fits within the Psychiatry Physician landscape nationally.
FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s 6,112 claims are above the specialty average of 1,038.
Nearby Psychiatry Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as CATAO ALVES MARTINS DA SILVA.
Compare Psychiatry Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s specialty? ▼
How much does FABIO CATAO ALVES MARTINS DA SILVA, M.D. prescribe under Medicare Part D? ▼
What is FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s Medicare quality score? ▼
Where is FABIO CATAO ALVES MARTINS DA SILVA, M.D. located? ▼
What is FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s NPI number? ▼
Does FABIO CATAO ALVES MARTINS DA SILVA, M.D. prescribe more brand-name or generic drugs? ▼
How many Psychiatry Physician providers are there in the US? ▼
What drugs does FABIO CATAO ALVES MARTINS DA SILVA, M.D. prescribe most often? ▼
Does FABIO CATAO ALVES MARTINS DA SILVA, M.D. accept Medicare? ▼
How can I verify FABIO CATAO ALVES MARTINS DA SILVA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology